Skip to content
15% off your first order15% off your first order

SS-31 50 mg vial

Also known as Elamipretide

Mitochondrial repair

Investigated for cardiolipin binding and redox balance.

$329.00CAD· $6.58/mg
1
  • Ships from Canada in 1–2 business days
  • Free shipping over $120
  • Place your order, then send the e-Transfer. We pack it as soon as it arrives.

For research use only. Not for human consumption.

Complete your setup

Needles and wipes are free. Water is $19.

Compare. Side by side, from the research.

About SS-31

SS-31, also known as elamipretide, is studied for its affinity for the inner mitochondrial membrane. Research focuses on cardiolipin, a phospholipid central to mitochondrial efficiency.

How it works

Cardiolipin Affinity
Studied for selective binding to a phospholipid that shapes the structure of the inner mitochondrial membrane.
Redox Balance
Explored for effects on electron-transport efficiency and the oxidative by-products of energy production.
Read the full research

What you need

  • Bacteriostatic Water
  • Needles
  • Alcohol Wipes
  • A protocol guide comes with every order

Shipping & payment

  • Packed and dispatched within 1–2 business days
  • Delivered across Canada in 2–5 business days, tracked
  • Temperature-controlled packaging where the product needs it
  • Free shipping on orders over $120
  • Prices in CAD · pay by Interac e-Transfer
Format
Lyophilised powder in a sealed vial
Strength
50 mg per vial
Storage
Refrigerate, away from light. Once reconstituted, keep refrigerated and use within the window on the insert.
Reconstitution
2 mL bacteriostatic water for this 50 mg vial (25 mg/mL)
Route in research
Subcutaneous
SKU
2S50

Handling

  1. 1ReconstituteAdd bacteriostatic water down the side of the vial. Swirl, never shake. Agitation damages the peptide chain.
  2. 2StoreRefrigerate at 2–8°C once mixed. Reconstituted peptide is stable for the window given in your protocol guide.
  3. 3Measure with the calculator Use an insulin syringe at the units your protocol specifies. Rotate sites and log what you take.
Purity
High-performance liquid chromatography (HPLC), by an independent laboratory
Identity
Mass spectrometry, on the same batch
How often
Every batch
COA
The certificate of analysis is matched to the lot code printed on your vial
Evidence
Approved analog

Check your lot

Every vial carries a lot code. Enter it, or scan the QR on the label, to see its expiry and certificate of analysis.

Approved analogElamipretide (SS-31) has been evaluated in a phase 3 randomized clinical trial in primary mitochondrial myopathy, and a 2026 review titled 'Elamipretide: First Approval' reports its first regulatory approval.

What research examines

  • Cardiolipin binding in the inner mitochondrial membrane
  • Electron-transport efficiency and oxidative stress
  • Primary mitochondrial myopathy in a phase 3 clinical trial
  • Mitochondrial dysfunction in heart failure research
  • Synaptic and memory impairment in mouse models of inflammation
  • Cardiomyocyte hypoxia/reoxygenation injury in cell models

Reported in studies

  • Safety was an evaluated endpoint in the MMPOWER-3 phase 3 trial in primary mitochondrial myopathy
  • Specific adverse events are not summarized in the cited study titles
  • Much of the mechanistic evidence comes from animal and cell studies
Read the full research page· 5 cited studies

Published research protocols

5 mg, 3x/week, am

Research protocols have used 1–10 mg per administration, 3 times per week (morning), in 8-week blocks with 4 weeks off.

For research use only. These figures summarize published research protocols. They are not instructions or medical advice.

Measure with the calculator

CoreX AI

Ask about SS-31

Plain answers, from the basics to the studies.

Research information, not medical advice.

Often researched with SS-31

Researched for longevity & renewal.

Shop Longevity & renewal

FAQ

Questions, answered

  • SS-31, also known as elamipretide, is a peptide studied for its affinity for the inner mitochondrial membrane. Research centers on its interaction with cardiolipin, a phospholipid central to mitochondrial structure and efficiency. It has been investigated in preclinical models and in human clinical trials, including a phase 3 trial in primary mitochondrial myopathy, and a 2026 review reports its first regulatory approval.

  • Research describes SS-31 as concentrating in the inner mitochondrial membrane and interacting with cardiolipin, a phospholipid that shapes the membrane's structure. Through this interaction, it has been studied for effects on electron-transport efficiency and on the oxidative by-products generated during cellular energy production. These mechanistic descriptions come largely from laboratory and animal research and are summarized in published reviews of its structure and mechanism of action.

  • Studies have examined SS-31 in several settings. A phase 3 randomized trial, MMPOWER-3, assessed its efficacy and safety in primary mitochondrial myopathy. Reviews discuss targeting mitochondrial dysfunction in heart failure. Mouse research examined mitochondrial dysfunction, synaptic function and memory impairment induced by lipopolysaccharide, and cell studies have explored mitochondria-targeted formulations in cardiomyocyte hypoxia/reoxygenation injury. Findings vary by model and should be interpreted within each study's design.

  • Safety was formally assessed as an endpoint in the MMPOWER-3 phase 3 trial in individuals with primary mitochondrial myopathy, and regulatory approval implies a safety review for at least one indication. However, specific adverse events are not summarized in the cited study titles, and much of the mechanistic literature comes from animal and cell models. Researchers should consult the full clinical publications for detailed safety findings.

  • Research protocols have used 1–10 mg per administration by the subcutaneous route, 3 times per week in the morning, in 8-week blocks followed by 4 weeks off. These figures describe protocols reported in research settings and are not recommendations. Each CoreX order ships with a protocol guide for laboratory reference. SS-31 is supplied for laboratory research use only.

Vial

Senescent-cell research

FOXO4 10 mg

$219/ 10 mg